Back to search
FDAFDA · Food and drugs·Recall number D-0661-2016

Haloperidol Oral Solution, USP (Concentrate) 2 mg/mL 15 mL amber bottle, Rx Only, Manufactured by Silarx Pharmaceuticals Inc. Carmel, NY 10512, Packaged by Safecor Health, Woburn, MA 01801, NDC 54838-0501-40.

Published February 17, 2016 · Recall initiated: March 2, 2015

Summary

FDA records drug Class II recall D-0661-2016, published February 17, 2016 and initiated March 2, 2015. Recalling firm: Safecor Health, LLC; Status: Terminated; Reported quantity: 3,532 amber bottles; Lot: Lot #846881; Exp 01/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: Confirmed customer complaints of leaking bottles.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Safecor Health, LLC
Distributor
NJ
Lot
Lot #846881; Exp 01/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Haloperidol Oral Solution, USP (Concentrate) 2 mg/mL 15 mL amber bottle, Rx Only, Manufactured by Silarx Pharmaceuticals Inc. Carmel, NY 10512, Packaged by Safecor Health, Woburn, MA 01801, NDC 54838-0501-40. recalled?

Yes. FDA published recall D-0661-2016 on February 17, 2016. Reported hazard: Defective Container: Confirmed customer complaints of leaking bottles.

What should I do if I have this product?

Voluntary: Firm initiated · Letter